ACArturo Cruz-Salgado

Arturo Cruz-Salgado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arturo Cruz-Salgado has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vacunación en personas adultas y adultas mayores en México

    by Norma Mongua-Rodríguez, Leticia Ferreyra-Reyes, Elizabeth Ferreira-Guerrero, Guadalupe Delgado-Sánchez, Maribel Martínez-Hernández, Sergio Canizales-Quintero, Norma Aracely Tellez-Vázquez, Arturo Cruz-Salgado, Luis Miguel Gutierrez-Robledo, Lourdes García-García

    Objetivo. Estimar la proporción de sujetos vacunados y los factores asociados en personas adultas y adultas mayores en México. Material y métodos. Análisis de datos obtenidos de la Encuesta Nacional de Salud y Nutrición Continua 2021-2023 (Ensanut Continua 2021-2023) y analizar las variaciones comparando con la Ensanut 2012. Resultados. Dado que solamente el 6.8% de personas adultas y adultas mayores en Ensanut Continua 2021-2023 y 17.7% en Ensanut 2012 acreditaron su estado de vacunación, el análisis se basa en autorreporte. Al comparar Ensanut Continua 2021-2023 con Ensanut 2012, la proporción de sujetos vacunados de acuerdo con grupo de edad y biológico fue la siguiente: personas de 20-59 años, tétanos: 66.87 vs. 78.08%; mujeres en edad fértil, tétanos: 71.1 vs. 82.0%; sarampión/rubéola: 36.8 vs. 48.5%; adultos mayores: tétanos: 59.5 vs. 65.86%; influenza 58.7 vs. 51.9%; neumococo 34.8 vs. 45.9%. La cobertura para vacuna contra Covid-19 en adultos jóvenes y mayores fue de 86.6 y 89.2%, respectivamente. Las características más prevalentes entre los adultos de 20-59 años con esquemas incompletos fueron ser hombre, no tener derechohabiencia y tener trabajo remunerado; en los adultos ≥ 60 años fue no tener derechohabiencia. Discusión. Una proporción considerable de personas adultas y adultas mayores no están protegidos contra enfermedades prevenibles por vacunación en 2021-2023.


  • Open Access

    Enfermedad diarreica e infección respiratoria aguda en menores de cinco años

    by Guadalupe Delgado-Sánchez, Elizabeth Ferreira-Guerrero, Leticia Dolores Ferreyra-Reyes, Norma Mongua-Rodríguez, Maribel Martínez-Hernández, Sergio Canizales-Quintero, Norma Aracely Téllez-Vázquez, Arturo Cruz-Salgado, Lourdes García-García

    Objetivo. Analizar las tendencias del porcentaje de enfermedad diarreica aguda (EDA) e infección respiratoria aguda (IRA) y factores asociados en niñas y niños menores de cinco años en México. Material y métodos. Se estimaron los porcentajes de EDA e IRA en las dos semanas previas a la entrevista, con base en la Encuesta Nacional de Salud y Nutrición Continua 2021-2023 (Ensanut Continua 2021-2023) y se compararon con las reportadas en las Ensanut 2006, 2012 y 2018. Se identificaron, mediante regresión logística múltiple, factores asociados a EDA e IRA en 2021-2023. Resultados. Se estimó 7.8% de ocurrencia de EDA y 21.3% de IRA en 2021-2023, menores a años previos. Presentar EDA se asoció con tener uno o dos años vs. cuatro años; residir en las regiones pacífico-norte, pacífico-centro, centro-norte, Ciudad de México, Estado de México, pacífico-sur y la península vs. la frontera; y que una mujer sea jefa del hogar. Presentar IRA se asoció con hogares con nivel bajo de bienestar vs. nivel alto en las regiones pacífico-norte, la frontera, centro-norte, pacífico-sur y la península vs. el Estado de México. Conclusiones. Se recomienda fortalecer las capacidades de las autoridades de salud de los distintos niveles, con la sociedad civil, para prevenir la EDA y la IRA y asegurar acceso al agua potable con perspectiva de género.


  • Open Access

    Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma

    by Cristina Trejo-Solis, Daniela Silva-Adaya, Norma Serrano-García, Roxana Magaña-Maldonado, Dolores Jimenez-Farfan, Elizabeth Ferreira-Guerrero, Arturo Cruz-Salgado, Rosa Angelica Castillo-Rodriguez

    Glioma cells exhibit genetic and metabolic alterations that affect the deregulation of several cellular signal transduction pathways, including those related to glucose metabolism. Moreover, oncogenic signaling pathways induce the expression of metabolic genes, increasing the metabolic enzyme activities and thus the critical biosynthetic pathways to generate nucleotides, amino acids, and fatty acids, which provide energy and metabolic intermediates that are essential to accomplish the biosynthetic needs of glioma cells. In this review, we aim to explore how dysregulated metabolic enzymes and their metabolites from primary metabolism pathways in glioblastoma (GBM) such as glycolysis and glutaminolysis modulate anabolic and catabolic metabolic pathways as well as pro-oncogenic signaling and contribute to the formation, survival, growth, and malignancy of glioma cells. Also, we discuss promising therapeutic strategies by targeting the key players in metabolic regulation. Therefore, the knowledge of metabolic reprogramming is necessary to fully understand the biology of malignant gliomas to improve patient survival significantly.


  • Open Access

    Caracterización del bienestar en hogares mexicanos de niñas y niños con diarrea, Ensanut Continua 2022

    by Guadalupe Delgado-Sánchez, Norma Mongua-Rodríguez, Leticia Ferreyra-Reyes, Edith Elizabeth Ferreira-Guerrero, Maribel Martínez-Hernández, Norma Araceli Téllez-Vázquez, Sergio Canizales-Quintero, Arturo Cruz-Salgado, Lourdes García-García

    Objective. To analyze the level of welfare in Mexican households of children under five who presented acute diarrheal disease (ADD) in the last two weeks in Mexico, according to the National Health Survey (Ensanut) Continua 2022. Materials and methods. The survey was conducted between July and December 2022. Dependent variable: to presentADD. Independent variable: level of welfare house. Bivariate and logistic regression crude and adjusted analyses were performed. Results. It is estimated that 9.4% of children under five years of age presented ADD; of these, 76.4% (95%CI: 69.0,82.5) belonged to households with low-medium levels of well-being. Having ADD was more frequent in 1-year-old children (aOR 3.00; 95%CI: 1.76,5.11), compared to those younger than 1 year;and belonging to households where water is not treated (aOR 2.13; 95%CI: 1.11,4.08). Conclusions. It is a priority to strengthen sanitary measures to prevent ADD in one-year-old children, as well as implement actions to ensure the availability of drinking water or its adequate treatment for drinking. It is necessary to plan, execute and evaluate integral and multisectoral public policy actions that help to guarantee the human right to health in childhood.


  • Open Access

    Vacunación en adultos y adultos mayores en México

    by Norma Mongua-Rodríguez, Elizabeth Ferreira-Guerrero, Guadalupe Delgado-Sánchez, Leticia Ferreyra-Reyes, Maribel Martínez-Hernández, Sergio Canizales-Quintero, Norma Aracely Téllez-Vázquez, Arturo Cruz-Salgado, Lourdes García-García

    Objetivo. Estimar la prevalencia del antecedente de vacunación en adultos de 20 a 59 años y mayores de 60 años mediante autorreporte. Material y métodos. Análisis de datos obtenidos de la Encuesta Nacional de Salud y Nutrición 2022 (Ensanut 2022). Resultados. El 27.4% de los adultos de 20-39 años refirió haber recibido vacuna doble viral (sarampión y rubeola [SR]) y 57.3% de adultos de 20-59 años cualquier vacuna con toxoide tetánico (Td) en los últimos diez años. En mujeres de 29 a 49 años, 18.7% (IC95%: 17.0,20.5) y 58.46% (IC95%: 56.2,60.7) habían sido vacunadas con vacuna SR y Td, respectivamente. En mayores de 60 años, 48.8% (IC95%: 45.9,51.7), 24.4% (IC95%: 22.2,26.8) y 49.1% (IC95%: 46.1,52.2) informaron haber recibido cualquier vacuna conteniendo Td, vacuna antineumococo y vacuna antiinfluenza estacional desde septiembre del año anterior a la encuesta, respectivamente. Conclusión. Los resultados de este estudio muestran que una proporción considerable de adultos, mujeres en edad fértil y adultos mayores no estaban protegidos contra enfermedades prevenibles por vacunación en 2022.


  • Open Access

    Porcentaje de infección respiratoria aguda en menores de cinco años en México. Ensanut Continua 2022

    by Elizabeth Ferreira-Guerrero, Guadalupe Delgado-Sánchez, Norma Mongua- Rodríguez, Maribel Martínez-Hernández, Sergio Canizales-Quintero, Leticia Dolores Ferreyra-Reyes, Norma Araceli Téllez-Vázquez, Arturo Cruz-Salgado, Lourdes García-García

    Objective. To estimate the percentage of acute respiratory infections (ARI) in Mexican children under five years of age in the last two weeks, according to the Encuesta Nacional de Salud y Nutricion Continua 2022 (Ensanut Continua 2022). Materials and methods. We analyzed data from the Ensanut Continua 2022. Results. The percentage of ARI was 27.6% (95%CI: 25.2,30.1). The prevalence was higher in households with lower economic capacity (first tertile) (44.1% [95%CI: 38.0,50.4]).The most identified ARI alarm sign was "looking sicker" 33.0% (95%CI: 30.1,36.0), and the least was "pus coming out of the ear" (1.5% [95% CI: 0.9,2.7]). Conclusions. ARI affect about a third of children under five years of age in Mexico, particularly from households with lower economic capacities. It is necessary to strengthen prevention strategies including vaccination, control, and health promotion.


  • Open Access

    Porcentaje de enfermedad diarreica aguda en menores de cinco años en México. Ensanut Continua 2022

    by Guadalupe Delgado-Sánchez, Elizabeth Ferreira-Guerrero, Leticia Ferreyra-Reyes, Norma Mongua-Rodríguez, Maribel Martínez-Hernández, Sergio Canizales-Quintero, Norma Téllez-Vázquez, Arturo Cruz-Salgado, Lourdes García-García

    Objective. To estimate the percentage of acute diarrheal disease (ADD) in children under five years of age in the last two weeks, according to data from the Encuesta Nacional de Salud y Nutricion Continua 2022 (Ensanut Continua 2022). Materials and methods. Data for children under five years included in the Ensanut Continua 2022 regarding ADD in the last two weeks were analyzed. These data were compared with those of previous Ensanut. Results.The percentage of ADD in Mexico was 9.4% (95%CI: 7.9,11.2), similar to that of 2000; with differences by age group. During the ADD episode, 38.7% (95%CI: 27.7,51.0) of caregivers offer less amount of food. Conclusions. The high percentage of ADD in children under five years in Mexico in 2022 shows the need to strengthen prevention and health promotion strategies.


  • Open Access

    Knowledge, attitudes, perceptions, and COVID-19 hesitancy in a large public university in Mexico city during the early vaccination rollout

    by Norma Mongua-Rodríguez, Mauricio Rodríguez-Álvarez, Daniela De-La-Rosa-Zamboni, María Eugenia Jiménez-Corona, Martha Lucía Castañeda-Cediel, Guadalupe Miranda-Novales, Gustavo Cruz-Pacheco, Elizabeth Ferreira-Guerrero, Leticia Ferreyra-Reyes, Guadalupe Delgado-Sánchez, et al.

    Background: Vaccination against COVID-19 is a primary tool for controlling the pandemic. However, the spread of vaccine hesitancy constitutes a significant threat to reverse progress in preventing the disease. Studies conducted in Mexico have revealed that vaccination intention in Mexico among the general population ranges from 62 to 82%. Objective: To know the prevalence of COVID-19 vaccine hesitancy and associated factors among academics, students, and administrative personnel of a public university in Mexico City. Methods: We administered an online survey investigating sociodemographic aspects, knowledge, attitudes, practices, and acceptance/hesitancy regarding the COVID-19 vaccine. Using generalized linear Poisson models, we analyzed factors associated with vaccine hesitancy, defined as not intending to be vaccinated within the following six months or refusing vaccination. Results: During May and June 2021, we studied 840 people, prevalence of vaccine hesitancy was 6%. Hesitancy was significantly associated with fear of adverse effects, distrust of physician’s recommendations, lack of knowledge regarding handwashing, age younger than 40 years, refusal to use face masks, and not having received influenza vaccination during the two previous seasons. Conclusions: Vaccine hesitancy in this population is low. Furthermore, our results allowed us the identification of characteristics that can improve vaccine promotion.


  • Open Access

    Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation

    by Cristina Trejo-Solís, Dolores Jimenez-Farfan, Sara Rodriguez-Enriquez, Francisca Fernandez-Valverde, Arturo Cruz-Salgado, Lena Ruiz-Azuara, Julio Sotelo

    Background: Glioblastoma multiforme (GBM) is the most aggressive of the primary brain tumors, with a grim prognosis despite intensive treatment. In the past decades, progress in research has not significantly increased overall survival rate. Methods: The in vitro antineoplastic effect and mechanism of action of Casiopeina III-ia (Cas III-ia), a copper compound, on rat malignant glioma C6 cells was investigated. Results: Cas III-ia significantly inhibited cell proliferation, inducing autophagy and apoptosis, which correlated with the formation of autophagic vacuoles, overexpression of LC3, Beclin 1, Atg 7, Bax and Bid proteins. A decrease was detected in the mitochondrial membrane potential and in the activity of caspase 3 and 8, together with the generation of intracellular reactive oxygen species (ROS) and increased activity of c-jun NH2-terminal kinase (JNK). The presence of 3-methyladenine (as selective autophagy inhibitor) increased the antineoplastic effect of Cas III-ia, while Z-VAD-FMK only showed partial protection from the antineoplastic effect induced by Cas III-ia, and ROS antioxidants (N-acetylcysteine) decreased apoptosis, autophagy and JNK activity. Moreover, the JNK –specific inhibitor SP600125 prevented Cas III-ia-induced cell death. Conclusions: Our data suggest that Cas III-ia induces cell death by autophagy and apoptosis, in part due to the activation of ROS –dependent JNK signaling. These findings support further studies of Cas III-ia as candidate for treatment of human malignant glioma.